Cure My Disease

Don't miss your cure!

 Log in / Sign up

A simple idea to stop STIs: send treatment home with the patient

NCT ID NCT04553211

Prevention Sponsor: University of California, Los Angeles Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 01, 2026 · Last updated Sep 02, 2026 · Updated 1 time

Summary

This trial tests a strategy called expedited partner therapy (EPT) for men who have sex with men in Peru. When a participant is diagnosed with gonorrhea or chlamydia, they receive antibiotic packets to give to their recent sexual partners, so those partners can get treated without a doctor's visit. Researchers will compare this approach to standard partner notification counseling to see if it increases the number of partners who are notified, treated, and tested for HIV and other STIs. The goal is to reduce the spread of STIs and HIV in this community.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Expedited Partner Therapy (EPT), which provides antibiotic treatment packets for recent sexual partners of people diagnosed with gonorrhea or chlamydia
What this could lead to
If it works, this approach could reduce repeat STI infections and help curb HIV transmission among men who have sex with men in Peru, potentially informing broader prevention guidelines.
What could go wrong
This is a behavioral intervention, so its success depends on whether participants actually share the treatment packets. The trial is also limited to one region, so results may not apply elsewhere.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

663 people

The number who actually took part.

Started

Apr 2022

Finished

Apr 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Male participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Anatomically male at birth 2. Condomless anal intercourse with an HIV serodiscordant or unknown serostatus male or transgender female partner in the previous 6 months 3. 18 years of age or older 4. Diagnosis of Gonorrhea and/or Chlamydia infection at any anatomic site at the Screening visit Exclusion Criteria: 1\) Inability to understand the study procedures or to provide informed consent

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chlamydia are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chlamydia infectious disease chlamydia trachomatis infectious disease gonorrhea HIV infectious disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Chlamydia Gonorrhea male HIV-1-infection Partner communication

Contacts and locations

Locations

  • Asociacion Civil Via Libre

    Lima, Lima Province, 01, Peru

More trials for these conditions

Other studies related to the condition(s) this trial covers.